HONOREE AND SPEAKER
ICRF is proud to honor Dubi Fishel.
Dubi Fishel was born in 1948 in Tel Aviv, the same year Israel became an independent state. This year, both Dubi and Israel are celebrating 70 years.
Dubi was raised in Israel, and like all Israelis, served in the military. He was active in the Six-Day War, the Yom Kippur War, and the Lebanon War. For nearly two decades, Dubi and his wife Francine lived on Kibbutz Urim in the Western Negev, raising their three children, Daphna, Gilead, and Carin. Dubi was a leader in agriculture development and textile manufacturing.
Dubi and his family moved to the United States in 1984, making their home in Northbrook, Illinois. For over 25 years, Dubi worked as an Operations Executive in several manufacturing industries and then ran his own consulting business. Dubi has also been a dedicated volunteer for the Village of Northbrook, as a producer and director of NBK-TV. In addition, he has devoted time to Keshet, an organization supporting individuals with disabilities.
In July 2017, Dubi was diagnosed with Stage 4 Pancreatic Cancer. He is fighting this disease with the same strength, determination, and grace that he approaches every challenge in his life. He is an inspiration to all who know him.
Dubi supports the advances in cancer treatments of ICRF-funded scientists. Since being introduced to ICRF, Dubi has been working tirelessly for the organization. He made it his mission to share his story and generate support for ICRF and cutting-edge cancer research in Israel to help all humankind.
ICRF is excited to be joined by special guest speaker, Professor Ronit Satchi-Fainaro, PhD, Chair of the Department of Physiology and Pharmacology at the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Professor Ronit Satchi-Fainaro, PhD, a trailblazer in the field of nanoscience and nanomedicine, is on the front lines of cancer research. With a team of over 20 in her lab, these cancer researchers are "rewriting the war on cancer" by focusing on the design and characterization of novel drug delivery platforms.
Led by Prof. Satchi-Fainaro, they have developed revolutionary techniques to transport the right combination of cancer drugs, using nanomedical "taxis," directly to the malignancies, more effectively killing tumors and reducing toxic side-effects. Her groundbreaking research is helping increase survival rates of patients with pancreatic and other cancers. Her vision is to transform cancer into a chronically-manageable disease.
In 2014, Forbes-Israel named Prof. Ronit Satchi-Fainaro one of Israel's Most Influential Women. ICRF is proud to support Prof. Satchi-Fainaro with a prestigious 7-year Professorship Grant.